Company intelligence
NHTA
Your Global Market Access Partner From Strategy To Implementation
About NHTA
NHTA is a Global Market Access consultancy specialized in evidence generation, health economics, market access, and communication. Our mission is to elevate the bar for market access and health economics. We want to deliver the optimal solution – nothing less. It is not always easy to practice what you preach, but we try to. To meet the future standards of market access we have chosen to let our work be guided by values instead of profit margins. To deliver the optimal solution our recipe is simple: – We push the envelope for innovation by being industry experts in market access and health economics. – We listen to our client’s needs. – We focus on the objective. – We provide honest and realistic feedback and welcome the same. – We deliver on time. We embrace a close partnership with our clients and strive to find optimal solutions to every challenge. We believe in having open dialogues and provide our clients with honest feedback and welcome the same.
Verified activity
Signals from NHTA
4 published signals
Research & Knowledge
NHTA updated the first-line multiple myeloma recommendation stating that for at least 60% of patients, the drug for Louder should remain first choice.
Reported by NHTA
Research & Knowledge
NHTA updated assessment reports to include a new section on patients’ perspectives from December 2026.
Reported by NHTA
Products & Services
NHTA announced that the Danish Medicines Council will launch a new digital assessment portal on 5 October 2026.
Reported by NHTA
Research & Knowledge
NHTA published a new overview and algorithm for Medicinrådet's type 2 diabetes recommendations, including efficacy, prices, side effects, and other details, replacing the previous medicine recommendation and part of the national basis list in autumn 2026.
Reported by NHTA